Role of the Bone Marrow Microenvironment in the Development of Multiple Myeloma

Clark W Distelhorst

Bcl-2 Function on the Endoplasmic Reticulum

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies

Nikhil C Munshi

Role of Combination Therapy with Novel Targeted Agents

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies

Antonio Fojo

Clinical, Basic, Translational and Kinetic Studies of Drug Action and Resistance

Prostate Multiple myeloma and immunoproliferative diseases Breast All cancers but non-melanoma skin cancer

Irene M. Ghobrial

The role of miRNA15a and 16-1 in Multiple Myeloma

Multiple myeloma and immunoproliferative diseases

Daniel M Sullivan

CRM1 INHIBITORS SENSITIZE MULTIPLE MYELOMA CELLS TO TOPOISOMERASE II AND PROTEASOME INHIBITORS

Multiple myeloma and immunoproliferative diseases

Alan K Lichtenstein

Sensitivity of multiple myeloma cells to mTOR inhibitors

Multiple myeloma and immunoproliferative diseases

Nikhil C Munshi

Genomics Core

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Donna Reece

Expediting Patient-Oriented Research in Canada: Development of Myeloma Canada Research Network (MCRN)

Multiple myeloma and immunoproliferative diseases

Teru Hideshima

Functional and biologic significance of deacetylase3 inhibition in myeloma

Multiple myeloma and immunoproliferative diseases